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This book is written primarily for clinicians and clinical pathologists who are faced with the practical problems of dicumarol administration. It is well established that dicumarol lowers mortality from thromboembolic disease, but the effects of the drug are delayed, cumulative, and prolonged, and there is much variation in the response of different individuals. Therefore, the drug must be administered with knowledge of the dicumarol effect and with careful laboratory control in each case. Then, the desired therapeutic effect . . . be achieved with minimal danger of hemorrhage.
The difficulty of gauging from any in vitro test the tendency to thrombose or the tendency to bleed is fully appreciated by the autlhors. Moreover, they emphasize that the one-stage "prothrombin-time" does not measure percentage of prothrombin. Nevertheless, experience has shown the "prothrombin-time" to be a useful indicator of dicumarol effect.
In dealing with blood coagulation theory, the authors are in the position of impartial reviewers; and their discussion could hardly avoid the divergent concepts now prevailing. On the practical side, Shapiro and WVeiner are leaders in their field. The Link-Shapiro modification of the Quick test has found wide use. Their extensive clinical studies, along with the experiences of others, are briefly and lucidly summarized. There is an interesting chapter on dicumarol levels in plasma and an appendix of laboratory procedures. 
